Cargando…
Construction and validation of a novel ten miRNA-pair based signature for the prognosis of clear cell renal cell carcinoma
BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is the most predominate pathological subtype of renal cell carcinoma, causing a recurrence or metastasis rate as high as 20% to 40% after operation, for which effective prognostic signature is urgently needed. METHODS: The mRNA and miRNA profiles o...
Autores principales: | Wang, Yulin, Shen, Ziyan, Mo, Shaocong, Dai, Leijie, Song, Biao, Gu, Wenchao, Ding, Xiaoqiang, Zhang, Xiaoyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421317/ https://www.ncbi.nlm.nih.gov/pubmed/35998436 http://dx.doi.org/10.1016/j.tranon.2022.101519 |
Ejemplares similares
-
Comprehensive Analysis of the Systemic Transcriptomic Alternations and Inflammatory Response during the Occurrence and Progress of COVID-19
por: Mo, Shaocong, et al.
Publicado: (2021) -
Construction of the metabolic reprogramming-associated gene signature for clear cell renal cell carcinoma prognosis prediction
por: Tai, Rongfen, et al.
Publicado: (2023) -
A novel prognostic signature for clear cell renal cell carcinoma constructed using necroptosis-related miRNAs
por: Yu, Zuhu, et al.
Publicado: (2023) -
A Novel Defined PANoptosis-Related miRNA Signature for Predicting the Prognosis and Immune Characteristics in Clear Cell Renal Cell Carcinoma: A miRNA Signature for the Prognosis of ccRCC
por: Wang, Yanmei, et al.
Publicado: (2023) -
Construction of a novel gene-based model for prognosis prediction of clear cell renal cell carcinoma
por: Zhang, Zedan, et al.
Publicado: (2020)